Search Results - Erica S. Klaassen
- Showing 1 - 2 results of 2
-
1
First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator by Sebastiaan J. W. vanKraaij, Pim Gal, Laura G. J. M. Borghans, Erica S. Klaassen, Francis Dijkstra, Christopher Winrow, Chad Glasser, Geert Jan Groeneveld
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers by Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters, Melanie Rijsbergen, Erica S. Klaassen, Gary Feiss, Edwin Florencia, Errol P. Prens, Jacobus Burggraaf, Martijn B.A. vanDoorn, Robert Rissmann, Matthijs Moerland
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book